Published in Adv Neurol on January 01, 1998
Phenomenology and classification of dystonia: a consensus update. Mov Disord (2013) 4.98
Mutations in GNAL cause primary torsion dystonia. Nat Genet (2012) 3.66
TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A (2004) 2.06
Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol (2013) 1.90
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A (2004) 1.78
The cerebellum and basal ganglia are interconnected. Neuropsychol Rev (2010) 1.70
Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet (2007) 1.62
Task-specific dystonias: a review. Ann N Y Acad Sci (2008) 1.54
Primary dystonia: molecules and mechanisms. Nat Rev Neurol (2009) 1.51
Treatment of dystonia with deep brain stimulation. Neurotherapeutics (2008) 1.50
Novel THAP1 sequence variants in primary dystonia. Neurology (2010) 1.42
Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice. Exp Neurol (2008) 1.29
High-throughput mutational analysis of TOR1A in primary dystonia. BMC Med Genet (2009) 1.14
A family study on primary blepharospasm. J Neurol Neurosurg Psychiatry (2006) 1.13
Consequences of the DYT1 mutation on torsinA oligomerization and degradation. Neuroscience (2008) 1.10
Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet (2011) 1.08
Dystonia: phenomenology. Parkinsonism Relat Disord (2012) 1.04
A novel locus for autosomal recessive primary torsion dystonia (DYT17) maps to 20p11.22-q13.12. Neurogenetics (2008) 1.03
The subthalamic nucleus in primary dystonia: single-unit discharge characteristics. J Neurophysiol (2009) 1.00
Cortically evoked long-lasting inhibition of pallidal neurons in a transgenic mouse model of dystonia. J Neurosci (2008) 0.98
Botulinum toxin type A in the treatment of patients with cervical dystonia. Biologics (2009) 0.98
The treatment of movement disorders by deep brain stimulation. Neurotherapeutics (2008) 0.96
The genetics of dystonias. Adv Genet (2012) 0.96
Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? Mov Disord (2010) 0.96
Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci (2011) 0.94
Effect of electrode contact location on clinical efficacy of pallidal deep brain stimulation in primary generalised dystonia. J Neurol Neurosurg Psychiatry (2007) 0.94
Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet (2005) 0.94
Sporadic adult onset dystonia: sensory abnormalities as an endophenotype in unaffected relatives. J Neurol Neurosurg Psychiatry (2007) 0.94
Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia. Mov Disord (2010) 0.93
Dysregulation of striatal dopamine release in a mouse model of dystonia. J Neurochem (2010) 0.91
Dystonia. BMJ Clin Evid (2008) 0.91
Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases. Neurol Sci (2012) 0.90
The sodium leak channel, NALCN, in health and disease. Front Cell Neurosci (2014) 0.90
Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics (2008) 0.89
The mechanisms of movement control and time estimation in cervical dystonia patients. Neural Plast (2013) 0.87
Head trauma in primary cranial dystonias: a multicentre case-control study. J Neurol Neurosurg Psychiatry (2006) 0.86
Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure. Neuroimage (2009) 0.86
Dystonia. BMJ Clin Evid (2011) 0.86
A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet (2000) 0.86
Mutation screening of the DYT6/THAP1 gene in Serbian patients with primary dystonia. J Neurol (2012) 0.85
Midazolam-induced acute dystonia reversed by diazepam. J Anaesthesiol Clin Pharmacol (2012) 0.85
RNA interference in neuroscience: progress and challenges. Cell Mol Neurobiol (2005) 0.84
Childhood onset generalised dystonia can be modelled by increased gain in the indirect basal ganglia pathway. J Neurol Neurosurg Psychiatry (2003) 0.84
Efficacy of zolpidem for dystonia: a study among different subtypes. Front Neurol (2012) 0.84
Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel. Mov Disord (2013) 0.83
Thalamocortical Connectivity Correlates with Phenotypic Variability in Dystonia. Cereb Cortex (2014) 0.83
Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia. Neuroscience (2009) 0.82
Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients. J Neural Transm (Vienna) (2011) 0.82
Designing clinical trials for dystonia. Neurotherapeutics (2014) 0.82
Primary dystonia: moribund or viable. Mov Disord (2013) 0.82
Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature. J Neural Transm (Vienna) (2016) 0.81
Late-onset primary dystonia in Zhejiang province of China: a service-based epidemiological study. Neurol Sci (2015) 0.81
Shock waves in the treatment of muscle hypertonia and dystonia. Biomed Res Int (2014) 0.81
Fixed dystonia in complex regional pain syndrome: a descriptive and computational modeling approach. BMC Neurol (2011) 0.81
A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Mol Genet Genomic Med (2014) 0.81
Focal dystonia and the Sensory-Motor Integrative Loop for Enacting (SMILE). Front Hum Neurosci (2014) 0.80
Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia. Br J Pharmacol (2006) 0.80
Neuropathological diagnostic considerations in hyperkinetic movement disorders. Front Neurol (2013) 0.80
Animal models of focal dystonia. NeuroRx (2005) 0.80
Current and emerging strategies for treatment of childhood dystonia. J Hand Ther (2014) 0.79
Current and future medical treatment in primary dystonia. Ther Adv Neurol Disord (2012) 0.79
Aberrant Oscillatory Activity during Simple Movement in Task-Specific Focal Hand Dystonia. Front Neurol (2012) 0.79
Invertebrate models of dystonia. Curr Neuropharmacol (2013) 0.79
DYT1 knock-in mice are not sensitized against mitochondrial complex-II inhibition. PLoS One (2012) 0.78
The environmental epidemiology of primary dystonia. Tremor Other Hyperkinet Mov (N Y) (2013) 0.78
Edrophonium Challenge Test for Blepharospasm. Front Neurosci (2016) 0.77
Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action. Curr Neurol Neurosci Rep (2014) 0.77
Anesthesia for pediatric deep brain stimulation. Anesthesiol Res Pract (2010) 0.77
Error-enhancing robot therapy to induce motor control improvement in childhood onset primary dystonia. J Neuroeng Rehabil (2012) 0.77
Focal dystonias of the hand and upper extremity. J Hand Surg Am (2008) 0.76
Spatial Discrimination Threshold Abnormalities are not Detected in a Pilot Study of DYT6 Dystonia Mutation Carriers. Tremor Other Hyperkinet Mov (N Y) (2012) 0.76
Functional recovery from chronic writer's cramp by brain-computer interface rehabilitation: a case report. BMC Neurosci (2014) 0.76
Dystonia. BMJ Clin Evid (2014) 0.76
Comparative characterization of single cell activity in the globus pallidus internus of patients with dystonia or Tourette syndrome. J Neural Transm (Vienna) (2014) 0.76
Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation. J Neurol Neurosurg Psychiatry (2000) 0.76
Basal ganglia modulation of thalamocortical relay in Parkinson's disease and dystonia. Front Comput Neurosci (2013) 0.76
Movement disorders at a university hospital emergency room. An analysis of clinical pattern and etiology. J Neurol (2008) 0.75
Medical treatment of dystonia. J Clin Mov Disord (2016) 0.75
Cutaneous and Mixed Nerve Silent Period Recordings in Symptomatic Paroxysmal Kinesigenic Dyskinesia. Open Neurol J (2016) 0.75
Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features. J Neural Transm (Vienna) (2010) 0.75
Health-related quality of life in segmental dystonia is improved by bilateral pallidal stimulation. J Neurol (2008) 0.75
Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials. J Neurol (2012) 0.75
Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia. Brain Sci (2013) 0.75
Deep brain stimulation of globus pallidus internus for DYT1 positive primary generalized dystonia. Med J Islam Repub Iran (2014) 0.75
Botulinum Toxin in Pediatric Neurology: Switching Lanes From Death to Life. Glob Pediatr Health (2015) 0.75
Genetics in dystonia: an update. Curr Neurol Neurosci Rep (2013) 0.75
Botulinum toxin clinic-based epidemiologic survey of adults with primary dystonia in East china. J Mov Disord (2012) 0.75
Clinical Management of Dystonia in Childhood. Paediatr Drugs (2017) 0.75
Forebrain knock-out of torsinA reduces striatal free-water and impairs whole-brain functional connectivity in a symptomatic mouse model of DYT1 dystonia. Neurobiol Dis (2017) 0.75
Long-term results of deep brain stimulation in a cohort of eight children with isolated dystonia. J Neurol (2016) 0.75
Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster. J Neural Transm (Vienna) (2010) 0.75
The clinical phenomenology and associations of trick maneuvers in cervical dystonia. J Neural Transm (Vienna) (2015) 0.75
[Dystonia]. Nervenarzt (2008) 0.75
Evaluation of the Edrophonium Challenge Test for Cervical Dystonia. Intern Med (2017) 0.75
Normal eyeblink classical conditioning in patients with fixed dystonia. Exp Brain Res (2014) 0.75
Corticocortical inhibition in human motor cortex. J Physiol (1993) 8.92
Mitochondrial complex I deficiency in Parkinson's disease. Lancet (1989) 5.72
Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
Servo action in the human thumb. J Physiol (1976) 4.93
Interhemispheric inhibition of the human motor cortex. J Physiol (1992) 4.77
Servo action in human voluntary movement. Nature (1972) 4.33
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Painful legs and moving toes. Brain (1971) 3.63
Validity and reliability of a rating scale for the primary torsion dystonias. Neurology (1985) 3.56
The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain (1994) 3.54
Writers' cramp-a focal dystonia. Brain (1982) 3.43
Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ (1998) 3.41
Outcome of investigation of patients with presenile dementia. Br Med J (1972) 3.39
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Stretch reflex and servo action in a variety of human muscles. J Physiol (1976) 3.29
Scope of a technique for electrical stimulation of human brain, spinal cord, and muscle. Lancet (1982) 3.26
The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology (1982) 3.26
Corticobasal degeneration. Brain (1989) 3.20
Stimulation of the human motor cortex through the scalp. Exp Physiol (1991) 3.16
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med (1980) 2.81
Motor cortex stimulation in intact man. 2. Multiple descending volleys. Brain (1987) 2.77
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76
Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry (1988) 2.74
Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry (1976) 2.72
Human walking and higher-level gait disorders, particularly in the elderly. Neurology (1993) 2.65
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
Manual motor performance in a deafferented man. Brain (1982) 2.63
The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology (2004) 2.59
Is the human stretch reflex cortical rather than spinal? Lancet (1973) 2.58
"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet (1976) 2.54
Movement disorders in multiple sclerosis. Mov Disord (1995) 2.53
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
The pathophysiology of primary dystonia. Brain (1998) 2.51
Pathophysiology of blepharospasm and oromandibular dystonia. Brain (1985) 2.50
A method of monitoring function in corticospinal pathways during scoliosis surgery with a note on motor conduction velocities. J Neurol Neurosurg Psychiatry (1986) 2.50
Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry (1988) 2.46
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol (1990) 2.45
Changes in the response to magnetic and electrical stimulation of the motor cortex following muscle stretch in man. J Physiol (1991) 2.44
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44
Attitudes of families to some aspects of Huntington's chorea. Psychol Med (1979) 2.40
A study of hereditary essential tremor. Brain (1994) 2.37
Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry (1986) 2.37
'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain (1988) 2.36
Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology (1992) 2.36
Disturbance of sequential movements in patients with Parkinson's disease. Brain (1987) 2.30
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
Abnormalities in central motor pathway conduction in multiple sclerosis. Lancet (1984) 2.30
Isolated single motor units in human muscle and their rate of discharge during maximal voluntary effort. J Physiol (1971) 2.28
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Delay in the execution of voluntary movement by electrical or magnetic brain stimulation in intact man. Evidence for the storage of motor programs in the brain. Brain (1989) 2.19
The sensory mechanism of servo action in human muscle. J Physiol (1977) 2.18
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatry (1976) 2.18
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet (1997) 2.16
Functional brain networks in DYT1 dystonia. Ann Neurol (1998) 2.14
Hysteria--a neurologist's view. Psychol Med (1986) 2.12
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem (1997) 2.10
Corticobasal degeneration. A clinical study of 36 cases. Brain (1994) 2.10
'Subcortical dementia': the neuropsychological evidence. Neuroscience (1988) 2.08
Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain (1995) 2.06
Ballistic flexion movements of the human thumb. J Physiol (1979) 2.06
Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. Mov Disord (2000) 2.06
Reciprocal inhibition between the muscles of the human forearm. J Physiol (1984) 2.05
Relationship between plasma propranolol concentration and relief of essential tremor. J Neurol Neurosurg Psychiatry (1979) 2.04
Teaching tape for the motor section of the unified Parkinson's disease rating scale. Mov Disord (1995) 2.03
Modulation of motor cortical excitability by electrical stimulation over the cerebellum in man. J Physiol (1991) 2.01
Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res (1995) 1.98
Motor cortex stimulation in intact man. 1. General characteristics of EMG responses in different muscles. Brain (1987) 1.98
Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet (1977) 1.96
Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet (1994) 1.95
Performance of simultaneous movements in patients with Parkinson's disease. Brain (1986) 1.95
Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents. Psychopharmacologia (1975) 1.93
Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients. Brain (1974) 1.93
How common is dementia in Parkinson's disease? Lancet (1984) 1.93
Percutaneous electrical stimulation of corticospinal pathways at the level of the pyramidal decussation in humans. Ann Neurol (1991) 1.93
Assessing tremor severity. J Neurol Neurosurg Psychiatry (1993) 1.92
Effect of vision and stance width on human body motion when standing: implications for afferent control of lateral sway. J Physiol (1993) 1.91
Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34. Ann Neurol (1990) 1.89
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology (1982) 1.88
Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1986) 1.88
Assessment of extrapyramidal disorders. Br J Clin Pharmacol (1981) 1.86
Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord (1994) 1.86
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone. Lancet (1973) 1.85
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry (1986) 1.84
Different sites of action of electrical and magnetic stimulation of the human brain. Neurosci Lett (1987) 1.84
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
Botulinum toxin treatment of spasmodic torticollis. J R Soc Med (1992) 1.81
New observations on the normal auditory startle reflex in man. Brain (1991) 1.80
The stiff leg syndrome. J Neurol Neurosurg Psychiatry (1997) 1.80
Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. J Neurol Neurosurg Psychiatry (1977) 1.79
Natural history of idiopathic torsion dystonia. Adv Neurol (1976) 1.79